SARAH FARMER: Open Payments
NPI 1083098420 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 25 payments from 12 companies in 2025. Trend: 2023 $802 · 2024 $673 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $97 |
| Neurocrine BioSciences, Inc. | 5 | $95 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lilly USA, LLC | 2 | $29 |
| PFIZER INC. | 1 | $26 |
| Corium, LLC | 2 | $26 |
| Alkermes, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: INGREZZA, VRAYLAR, FANAPT, CAPLYTA, MOUNJARO, ELIQUIS, Azstarys, Wegovy.
Industry payments across OH — which companies pay providers there.
